CDK6-话题@MedSci

#CDK6#

3篇内容 | 627人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2190886, encodeId=d15a219088664, content=<a href='/topic/show?id=0ef6105e95d' target=_blank style='color:#2F92EE;'>#KSHV#</a> <a href='/topic/show?id=6f01441162' target=_blank style='color:#2F92EE;'>#CDK6#</a> <a href='/topic/show?id=5bb011188041' target=_blank style='color:#2F92EE;'>#人类酶#</a>, objectTitle=Nat Commun：新研究揭示KSHV病毒劫持人类蛋白诱发癌症机制, objectType=article, longId=815675, objectId=fc068156e56e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240302/1709376677868_2185383.png, objectUrl=/article/show_article.do?id=fc068156e56e, replyNumber=0, likeNumber=8, createdTime=2024-03-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1553787, encodeId=85741553e878e, content=<a href='/topic/show?id=6f01441162' target=_blank style='color:#2F92EE;'>#CDK6#</a>, objectTitle=Blood：CDK6是携带NUP98融合蛋白的急性髓系白血病的一个新的潜在治疗靶点, objectType=article, longId=193458, objectId=f73b193458ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f73b193458ee, replyNumber=0, likeNumber=31, createdTime=2020-05-05, rootId=0, userName=shizhenshan, userId=541214427242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f73b193458ee, moduleTitle=Blood：CDK6是携带NUP98融合蛋白的急性髓系白血病的一个新的潜在治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f73b193458ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553786, encodeId=a8941553e86d2, content=<a href='/topic/show?id=6f01441162' target=_blank style='color:#2F92EE;'>#CDK6#</a>, objectTitle=Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长, objectType=article, longId=187870, objectId=4a7018e87076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7018e87076, replyNumber=0, likeNumber=32, createdTime=2020-02-13, rootId=0, userName=shizhenshan, userId=541214427242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7018e87076, moduleTitle=Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a7018e87076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553785, encodeId=96331553e85f6, content=<a href='/topic/show?id=6f01441162' target=_blank style='color:#2F92EE;'>#CDK6#</a>, objectTitle=ASCO 2016：CDK4/CDK6抑制剂Abemaciclib转移性乳腺癌II期临床试验积极结果（MONARCH 1试验）, objectType=article, longId=70373, objectId=0c80e0373e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c80e0373e2, replyNumber=0, likeNumber=20, createdTime=2016-06-11, rootId=0, userName=shizhenshan, userId=541214427242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c80e0373e2, moduleTitle=ASCO 2016：CDK4/CDK6抑制剂Abemaciclib转移性乳腺癌II期临床试验积极结果（MONARCH 1试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c80e0373e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CDK6

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#KSHV# #CDK6# #人类酶#

2024-03-04发表于上海

shizhenshan (审核中...)

前往app查看评论内容

#CDK6#

Blood：CDK6是携带NUP98融合蛋白的急性髓系白血病的一个新的潜在治疗靶点

2020-05-05

shizhenshan (审核中...)

前往app查看评论内容

#CDK6#

Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长

2020-02-13

shizhenshan (审核中...)

前往app查看评论内容

#CDK6#

ASCO 2016：CDK4/CDK6抑制剂Abemaciclib转移性乳腺癌II期临床试验积极结果（MONARCH 1试验）

2016-06-11

科室
- - 订阅+
  - 更多科室
工具
服务